News

WHI Shows Unopposed Estrogen Is Risk Neutral


 

From JAMA

In addition, the duration of CEE use in the WHI remains problematic since the median “adherent time” was 3.5 years. “Thus, the WHI results do not address the balance of risks and benefits associated with longer term estrogen use,” they said.

DR. JUNGHEIM and Dr. Colditz are at Washington University, St. Louis. These remarks were taken from their editorial comment accompanying Dr. LaCroix's report (JAMA 2011;305:1354-5). They reported no relevant financial disclosures.

Pages

Recommended Reading

FDA Approves Drug for Recurrent Preterm Birth : Progesterone injection 17P 'will be widely available,' nearly 5 years after an FDA panel's recommendation.
MDedge Endocrinology
AMG 479 Fails to Stem Resistance to Endocrine Therapy
MDedge Endocrinology
PCOS Shown to Be Manifesting at Younger Ages
MDedge Endocrinology
Valproate for Bipolar Disorder Carries PCOS Risk
MDedge Endocrinology
Steroids Linked to Fetal Growth Retardation
MDedge Endocrinology
Dutasteride Slows Early Prostate Ca Progression : REDEEM study included men with low-risk, early-stage disease followed with active surveillance.
MDedge Endocrinology
Docetaxel Slows PSA Progression in Prostate Ca
MDedge Endocrinology
Night Sweats in Menopause May Pose CHD Risk
MDedge Endocrinology
Fewer Embryos Being Transferred per Cycle
MDedge Endocrinology
New Approach to Uterine Prep Requires 81% Fewer Injections
MDedge Endocrinology